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Proteins Needed for Vesicle Budding from the Golgi Complex Are also 
Required for the Docking Step of Homotypic Vacuole Fusion
 
Albert Price, William Wickner, and Christian Ungermann
 
Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755-3844
 
Abstract. 
 
Vam2p/Vps41p is known to be required for 
transport vesicles with vacuolar cargo to bud from the 
Golgi. Like other VAM-encoded proteins, which are 
needed for homotypic vacuole fusion, we now report 
that Vam2p and its associated protein Vam6p/Vps39p 
are needed on each vacuole partner for homotypic fu-
sion. In vitro vacuole fusion occurs in successive steps 
of priming, docking, and membrane fusion. While prim-
ing does not require Vam2p or Vam6p, the functions of 
these two proteins cannot be fulfilled until priming has 
occurred, and each is required for the docking reaction 
which culminates in trans-SNARE pairing. Consistent 
with their dual function in Golgi vesicle budding and 
homotypic fusion of vacuoles, approximately half of the 
Vam2p and Vam6p of the cell are recovered from cell 
lysates with purified vacuoles.
Key words: Vps41/Vam2p • Vps39/Vam6p • priming • 
 
NSF/Sec18p • 
 
a
 
SNAP-Sec17p
 
Introduction
 
The fusion of cellular membranes during secretion, en-
docytosis, and organelle inheritance is essential for cellu-
lar compartmentation. Highly conserved proteins are in-
volved in fusion events throughout the cell and across
species. These include soluble NSF attachment protein
receptors (SNAREs),
 
1
 
 the ATP-driven chaperone NSF/
 
Sec18p and its partner proteins 
 
a
 
SNAP/Sec17p, and a large
family of Rab GTPases. The pairing in trans of cognate
v- (vesicle) and t- (target membrane) SNAREs is a central
event in docking membranes before fusion (Rothman,
1994; Hay and Scheller, 1997). This pairing is regulated
by the prior priming action of NSF/Sec18p and SNAP/
Sec17p, which prepares the SNAREs for docking, and by
Rab GTPases (Mayer and Wickner, 1997; Novick and Ze-
rial, 1997). The relationship of the structurally diverse Rab
effectors and tethering factors (Pfeffer, 1996; TerBush et
al., 1996; Cao et al., 1998; McBride et al., 1999) to docking
is currently studied for several trafficking reactions.
We have studied the homotypic fusion of yeast vacuoles.
It occurs in the ordered stages of priming, docking, and bi-
layer fusion. During priming, individual vacuoles are pre-
pared for interaction with other vacuoles. The starting vac-
uoles contain a cis complex of SNAREs bound together
on the same vacuole. This cis-SNARE complex includes
a t-SNARE (Vam3p), v-SNAREs (Nyv1p, Vti1p, and
Ykt6p), an s-SNARE (Vam7p, which is a homologue of
the synaptic SNAP-23/25 protein), an 
 
a
 
-SNAP (Sec17p;
Haas et al., 1995; Haas and Wickner, 1996; Nichols et
al., 1997; Ungermann and Wickner, 1998; Ungermann et
al., 1999a), as well as a novel chaperone (LMA1; Barlowe,
1997; Xu et al., 1997, 1998). In priming, the action of
Sec17p, Sec18p, and LMA1 disassembles the cis-SNARE
complex. Sec17p is released, the t-SNARE is activated,
and LMA1 stabilizes the primed t-SNARE (Mayer et al.,
1996; Ungermann et al., 1998; Xu et al., 1998). The primed
vacuoles come into contact during docking. The initial
tethering stage of docking is reversible and independent of
SNAREs, but requires Ypt7p, a small GTP-binding pro-
tein of the Rab family (Ungermann et al., 1998). The inter-
action between vacuoles becomes irreversible through the
association of SNARE proteins from apposed vacuoles,
forming a trans-SNARE complex. trans-SNARE pairing
triggers the release of lumenal calcium to interact with
calmodulin and mediate downstream events that lead to
fusion (Peters and Mayer, 1998). These events include the
release of LMA1 from the t-SNARE, which is regulated
by a phosphatase-kinase pair (Xu et al., 1998).
Mutations in the genes encoding many of the above pro-
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teins, which were shown biochemically to catalyze each
stage of the fusion reaction, cause severe vacuole fragmen-
tation in the intact cell, presumably reflecting a failure of
vacuole fusion. Type II vacuole morphology (
 
vam
 
) mu-
tants were obtained in a nonselective screen for just such a
highly fragmented vacuole morphology. Since Vam3p,
Vam4/Ypt7p, and Vam7p are each involved in the reac-
tion, we examined whether Vam2p and Vam6p are also re-
quired. These proteins are required for normal vacuole
morphology (Wada et al., 1992; Nakamura et al., 1997;
Zheng et al., 1998), for protein sorting to the vacuole
(Raymond et al., 1992; Cowles et al., 1997; Rehling et al.,
1999) and for cytosol-to-vacuole protein targeting (Hard-
ing et al., 1995). Though Vam2p and Vam6p are reported
to be localized to the vacuole (Wada et al., 1992) and to be
associated in a large complex (Nakamura et al., 1997),
Vps41p/Vam2p also fulfills a specific role in transport ves-
icle budding from the Golgi (Rehling et al., 1999,), where
it interacts with the AP3 coat. We now report that approx-
imately half of the Vam2p and Vam6p of the cell copuri-
fies with vacuoles, and that it is required for the docking
stage of homotypic vacuole fusion and for the formation of
stable trans-SNARE pairs.
 
Materials and Methods
 
Yeast Strains and Genetic Manipulations
 
Saccharomyces cerevisiae
 
 strains BJ3505 (MAT
 
a 
 
pep4::HIS3 prb1-
 
D
 
1.6R
HIS3 lys2-208 trp1-D101 ura3-52 gal2 can) and DKY 6281 (MATa leu2-3
leu2-112 ura3-52 his3-D200 trp1-D901 lys2-801 suc2-D9 pho8::TRP1)
were used. The 
 
VAM2
 
 and 
 
VAM6
 
 genes were disrupted in 
 
S
 
.
 
 cerevisiae
 
BJ3505 by recombination with PCR-generated cassettes containing 5
 
9
 
 and
3
 
9
 
 homologous regions of either 
 
VAM2
 
 or 
 
VAM6
 
 and the 
 
URA3
 
 gene of
 
S
 
.
 
 cerevisiae
 
. The PCR primers contained 40 bases of identity to the re-
gions flanking the open reading frame (
 
VAM6
 
 5
 
9
 
 primer sequence: 5
 
9
 
CAG CAA AAA CCC TTC AAA ATA TCA ATT TAT ACC AAA
AAT TAA GAT TCC GGT TTC TTT GAA AT 3
 
9
 
; 
 
VAM6
 
 3
 
9
 
 primer se-
quence 5
 
9
 
 ATA AGA AAT ACT AAC AAC AAT AAC AGC AGC
TGT TAA GGG ATC TCT AAT TTG TGA GTT TAG TAT AC 3
 
9
 
;
 
VAM2
 
 5
 
9
 
 primer sequence: 5
 
9
 
 AAA GCA TTT TAA CGA AGA GTA
TAT ACC TAC TAT TAG ACA TTA GAT TCC GGT TTC TTT GAA
AT 3
 
9
 
; and 
 
VAM2
 
 3
 
9
 
 primer sequence 5
 
9
 
 TGA AGT GTA CAC TTG
CCT TGT GTA TTA AAT GAT GAT TCG ATA TCT AAT TTG TGA
GTT TAG TAT AC 3
 
9
 
). Transformants were screened for the expected
deletion by PCR using primers that anneal to the promoter region of the
 
VAM2
 
 or 
 
VAM6
 
 genes (
 
VAM2
 
 primer sequence 5
 
9
 
 GGG CTA TTG
AGA CTGV TTG 3
 
9
 
; and 
 
VAM6
 
 primer sequence 5
 
9
 
 TAG GTT TAC
GGC TGT TCA A 3
 
9
 
), the coding region of the 
 
URA3
 
 gene (5
 
9
 
CCC AAT
GCG TCT CCC TT 3
 
9
 
), and isolated genomic DNA from the selected
clones by PCR (Ausubel et al., 1995). Deletions were confirmed by SDS-
PAGE immunoblotting (Harlow and Lane, 1988) with antibodies to
Vam2p and Vam6p.
 
Biochemical Reagents
 
All inhibitors and antibodies were dissolved in or dialyzed into PS buffer
(20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol) unless stated otherwise.
 
Antibody Production and Purification
 
Antibodies against the Vam2 and Vam6 proteins were raised in rabbits us-
ing recombinant His
 
6
 
-tagged proteins purified from 
 
Escherichia coli
 
. The
coding sequences for 
 
S
 
.
 
 cerevisiae
 
 
 
VAM2
 
 and 
 
VAM6
 
 were PCR amplified
(
 
VAM2
 
 5
 
9
 
 primer: 5
 
9s
 
 AGT ACC GGA TCC ATG ACT ACA GAT
AAT CAT 3
 
9
 
; 
 
VAM2
 
 3
 
9
 
 primer: 5
 
9
 
 AGT GTT GGT ACC TTA TAA
ACA CCA TTT AA 3
 
9
 
; 
 
VAM6
 
 5
 
9
 
 primer: 5
 
9
 
 AGT GTT GGT ACC TTA
CTT ATT ATT TAG GTC 3
 
9
 
; and 
 
VAM6
 
 3
 
9
 
 primer: 5
 
9
 
 AGT ACC GGA
TCC ATG TTA AGA GCT CAA AAG 3
 
9
 
) and cloned into pQE30
(Qiagen). Antibodies were affinity-purified using columns of recombinant
Vam2 or Vam6 proteins coupled to Affi-Gel (Bio-Rad Laboratories) and
dialyzed into PS buffer (20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol).
Fab fragments of anti-Vam2 were prepared by papain digestion (Immu-
noPure Fab kit; Pierce Chemical Co.), affinity-purified as described
above, and dialyzed into PS buffer. Antibodies against Ypt7p (Haas et al.,
1995), Sec18p (Haas and Wickner, 1996), and Vam3p (Nichols et al., 1997)
were purified as described previously and dialyzed into PS buffer.
 
Vacuole Fusion Assay
 
Vacuole isolation and fusion assays were performed as described previ-
ously (Haas, 1995).
 
Results
 
Vam2p and Vam6p Are Required on both Partner 
Vacuoles for Fusion
 
Vam2/Vps41p and Vam6/Vps39p, fused to green fluores-
cent protein, are localized to the vacuole in vivo
 
 
 
(Wada et
al., 1992) and, yet, Vam2p is also found associated with
AP-3 coat adapter subunits on the Golgi and is required
there for vesicle budding (Rehling et al., 1999). To deter-
mine whether the proportion of Vam2p and Vam6p recov-
ered with the vacuoles was consistent with vacuolar and/or
nonvacuolar localizations, we purified vacuoles from cell
lysates and compared the recovery of Vam2p and Vam6p
with that of Pho8p, an established vacuolar marker pro-
tein. We find that 45% of the Vam2p and 54% of the
Vam6p are recovered in our purified vacuoles, after cor-
rection for the loss of 23% of the vacuole marker Pho8p
during isolation (Fig. 1). The presence of Vam2p and
Vam6p in this fraction is not due to contaminating Golgi,
as 
 
,
 
5% of the late Golgi marker Kex2p is recovered with
the vacuoles (Fig. 1). Thus, half of the Vam2p and Vam6p
is localized to the vacuole while the rest is elsewhere in the
cell, in accordance with both Wada et al. (1992) and Re-
hling et al. (1999).
To investigate the functions of Vam2p and Vam6p, we
have employed an in vitro assay of vacuole fusion. Vacu-
oles are purified from two 
 
S
 
.
 
 cerevisiae 
 
strains bearing de-
letions in either the 
 
PEP4
 
 gene or the 
 
PHO8
 
 gene. Fusion
of these vacuoles exposes pro-alkaline phosphatase from
one vacuole population to its activating protease from the
Figure 1. Vam2p and Vam6p are
associated with purified vacuoles. A
BJ3505 wild-type culture was pro-
cessed for vacuole purification
(Haas, 1995). An aliquot of sphero-
plasted yeast cells was lysed by boil-
ing in SDS-PAGE loading buffer,
and the remaining spheroplasts
were carried through the vacuole
purification. Equivalent propor-
tions of spheroplasts and purified
vacuoles (0.1% of the total prepara-
tion) were analyzed by SDS-PAGE
and immunoblotting with antisera
against the indicated proteins. Re-
covery of proteins in the purified
vacuoles was determined by scan-
ning densitometry (see text).
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other, resulting in the production of enzymatically active
alkaline phosphatase, which is assayed spectrophotometri-
cally. The 
 
VAM2 
 
and 
 
VAM6 
 
genes were deleted in one of
our vacuole fusion tester strains, BJ3505. Although muta-
tions in 
 
VAM2
 
 and 
 
VAM6 
 
affect the rate of trafficking of
proteins to the vacuole in vivo (Nakamura et al., 1997;
Radisky et al., 1997), the steady state levels of the vacuolar
marker proteins Pho8p, CPY, and Vma1p are unaffected
in our purified vacuole preparations (Fig. 2 A). Thus,
whereas these vacuoles are smaller than wild type (Naka-
mura et al., 1997) and are often recovered with somewhat
lower yield, they contain the normal complement of vacu-
olar proteins. However, when normal amounts (assayed
by Bradford protein determination) of vacuoles derived
from BJ3505 
 
vam2
 
D
 
 or
 
 vam6
 
D
 
 strains are combined with
wild-type DKY6281 partner vacuoles in standard fusion
reactions, the resulting fusion is 
 
,
 
10% of that seen with
wild-type vacuoles (Fig. 2 B). Since these vacuoles have
normal levels of vacuole marker proteins (Fig. 2 A), ex-
cept for Vam2p or Vam6p, and since small vacuole size
alone is not a hindrance to fusion (see Fig. 4 b in Nichols et
al., 1997), the simplest inference is that Vam2p and Vam6p
are directly involved in fusion.
Affinity-purified antibodies to Vam2p or Vam6, or their
respective Fab fragments, efficiently inhibited in vitro vac-
uole fusion, whereas preimmune IgG did not (data not
shown). Since fusion is compromised when 
 
VAM2
 
 or
 
VAM6
 
 are deleted on only one vacuole fusion partner
(Fig. 2 B), we tested whether antibodies to Vam2p or
Vam6p inhibit fusion if added to only one partner vacuole.
Wild-type DKY6281 vacuoles were incubated on ice with
antibody to either Vam2p or Vam6p and reisolated to re-
move unbound antibody. These vacuoles were combined
with untreated or antibody-treated BJ3505 vacuole part-
ners in standard fusion reactions. Treatment of only one
vacuole type with antibody against Vam2p or Vam6p in-
hibited fusion (Fig. 3, lanes 3 and 4) to the same extent as
seen when both fusion partners were treated (Fig. 3, lanes
5 and 6). Thus, homotypic vacuole fusion requires Vam2p
and Vam6p on both fusion partners.
 
Vam2p and Vam6p Are Required for Docking
Sec18-primed Vacuoles
 
Previous studies of vacuole fusion in vitro have defined
three distinct reaction stages. First, priming requires the
action of Sec17p and Sec18p (Mayer et al., 1996). Second,
docking requires primed vacuoles, v- and t-SNAREs, and
Ypt7p (Mayer and Wickner, 1997; Ungermann and Wick-
ner, 1998). Third, fusion no longer requires trans-SNARE
pairs (Ungermann et al., 1998) but needs calmodulin (Pe-
ters and Mayer, 1998) and protein phosphatase 1 (Peters
et al., 1999). To determine the stages where Vam2p and
Vam6p act, aliquots were removed from vacuole fusion re-
actions at various times and mixed with buffer or inhibi-
tors, or placed on ice, and the incubation was continued
until all samples had been incubated for 90 min (Fig. 4). In
contrast to the inhibition by anti-Sec18p (closed squares),
which is only seen at early reaction times, resistance to
anti-Vam2p (crosses) and anti-Vam6p (closed triangles) is
achieved with intermediate kinetics that correspond to the
docking stage inhibitors Gdi1p (open triangles) or the an-
tibody to the t-SNARE Vam3p (diamonds; Mayer and
Wickner, 1997; Ungermann et al., 1998). Resistance to
anti-Vam2p and anti-Vam6p is achieved before fusion it-
self (open squares), suggesting that these factors are not
needed for the fusion stage of the reaction. These proteins
are also not involved in priming, since antibodies to
Figure 2. Vacuole fusion requires Vam2p and Vam6p. (A) Pro-
tein composition of vacuoles. Vacuolar protein (15 mg) from
wild-type, vam2D, and vam6D strains was analyzed by SDS-
PAGE and immunoblotting with antisera to the indicated vacu-
olar proteins. (B) In vitro fusion of vacuoles from wild-type,
vam2D, and vam6D strains. Standard vacuole fusion reactions
(see Materials and Methods) were performed with BJ3505 wild-
type, vam2D, or vam6D vacuoles combined with wild-type
DKY6281 vacuoles.
Figure 3. Active Vam2p and Vam6p are required on both vacu-
ole fusion partners. BJ3505 or DKY6281 vacuoles were mixed
with buffer or antibodies against Vam2p or Vam6p. After 10 min,
at 08C, vacuoles were diluted 20-fold with PS buffer and reiso-
lated to remove unbound antibody. Vacuole fusion partners were
combined in standard fusion reactions supplemented with cytosol
(30 mg/ml).
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Vam2p and Vam6p have no effect on Sec17p release from
the vacuoles (data not shown), indicating that these com-
ponents are not involved in priming (Mayer et al., 1996).
To further investigate the role of Vam2p and Vam6p in
docking, fusion reactions without inhibitors were started
with the partner vacuoles in separate tubes. At various
times, aliquots of each preincubated vacuole population
were combined with inhibitors and with each other, and
the reaction was continued for 70 min (Fig. 5). Resistance
to anti-Sec18p (closed squares) is achieved early, confirm-
ing that the priming subreaction can occur when vacuoles
are separated (Mayer et al., 1996). However, as with an
inhibitor of Ypt7p (open triangles), resistance to anti-
Vam2p (crosses) and anti-Vam6p (closed triangles) is
never achieved when the vacuole partners are in separate
tubes. Therefore, the action of Vam2p and Vam6p re-
quires contact between vacuole fusion partners and indi-
cates a role in docking.
Homotypic vacuole fusion requires the early action of
Sec18p to prime the vacuoles for subsequent docking
(Mayer et al., 1996; Mayer and Wickner, 1997). To deter-
mine whether priming is a prerequisite for the action of
Vam2p and Vam6p, a two-stage experiment was per-
formed in which the activity of Sec18p was inhibited by
anti-Sec18p antibody in the first incubation. After 30 min,
a time which otherwise suffices for the acquisition of resis-
tance to Gdi1p or to antibodies to Vam3p, Vam2p, or
Vam6p (Fig. 4), Sec18p activity was restored by the addi-
tion of Sec18 protein, and the reaction was continued in
the presence or absence of inhibitors. Fusion is restored by
the addition of Sec18p in the second incubation (Fig. 6,
lane 2). However, as with the docking inhibitors Gdi1p
and anti-Vam3p, the reaction remains fully sensitive to
anti-Vam2p and anti-Vam6p (Fig. 6, lanes 3–6). Thus,
Sec18p must act before Vam2p and Vam6p can fulfill their
functions.
We have previously reported that docking can be di-
vided into the stages of Ypt7p-dependent tethering, fol-
lowed by trans-SNARE pairing. These stages are distin-
guished by the addition of an excess of Sec18p to vacuole
fusion reactions, which allows Ypt7p to complete its func-
tion while preventing stable trans-SNARE pairing (Un-
germann et al., 1998). To examine the role of Vam2/6p in
docking, vacuoles were incubated under standard fusion
conditions for 20 min, but with an excess of Sec18p, and an
Figure 4. Kinetics of acquisition of resistance to Gdi1p and anti-
bodies to Vam3p, Vam2p, and Vam6p. Aliquots (30 ml) were re-
moved from 103 scale fusion reactions at the indicated times and
added to control buffer on ice, buffer at 278C, Gdi1p (64 mg/ml),
or antibodies against Sec18p, Vam3p, Vam2p, or Vam6p at 278C.
Fusion reactions were incubated for a total of 90 min at 278C be-
fore being assayed for alkaline phosphatase activity.
Figure 5. Completion of Vam2p and Vam6p function requires
vacuole docking. 103 scale reactions with vacuoles from either
BJ3505 or DKY6281 were incubated at 278C in the presence of
ATP. At the indicated times, 15-ml aliquots were removed from
each reaction and combined in the presence of control buffer on
ice, control buffer at 278C, Gdi1p, antibody to Vam3p, Vam2p, or
Vam6p at 278C, incubated for 70 min at 278C, and analyzed for
alkaline phosphatase activity.
Figure 6. The action of Sec18p must precede that of Vam2p and
Vam6p. A 103 scale fusion reaction with affinity-purified anti-
body against Sec18p was incubated at 278C for 30 min. The vacu-
oles were reisolated and resuspended in the original volume of
reaction buffer containing 25 mg/ml Sec18p and divided into 30-
ml aliquots. Where indicated, Gdi1p or antibodies against
Vam3p, Vam2p, or Vam6p were added. The incubations were
continued at 278C for 90 min and analyzed for alkaline phos-
phatase activity. The background activity of 0.22 U (a sample
transferred to ice after the first 30-min incubation) was sub-
tracted.
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aliquot was assayed for the fusion that had occurred (Fig.
7, lane 2). Other portions were sedimented to remove the
excess Sec18p and resuspended in buffer alone (lane 5) or
with other fusion inhibitors (Fig. 7, lanes 6–8) for a second,
70-min incubation. Whereas the reaction had become re-
sistant to Gdi1p (lane 6), it was still fully sensitive to anti-
body to Vam3p (lane 7) or to Vam2p (lane 8), suggesting
that Vam2/6p may complete its function after Ypt7p but
before SNAREs pair in trans.
To directly assay whether Vam2/6p is needed, after
priming and during docking, for the formation of trans-
SNARE pairs between the t-SNARE Vam3p on one vacu-
ole with the v-SNARE Nyv1p on another vacuole, we in-
cubated vacuoles from a vam3D strain with vacuoles from
a nyv1D strain, exploiting the fact that neither initial vacu-
ole population can have Vam3p:Nyv1p complexes (Unger-
mann et al., 1998b). As previously shown (see Fig. 5 C in
Ungermann et al., 1998b), the SNARE complexes that
form at 278C, and are assayed by the coprecipitation of
Nyv1p by antibody to Vam3p, are truly in trans (i.e., be-
tween apposed vacuoles), as their formation is not blocked
by Microcystin-LR, which is a potent inhibitor of fusion.
We find that the formation of trans-SNARE pairs in such
an assay (Fig. 8, lane 2) is blocked by antibody to Vam2p
(lane 3) or by its monovalent Fab fragment (lane 4), con-
firming that Vam2/6p is required for the completion of
docking.
Discussion
Vam2p and Vam6p are components of a multifunctional
complex that is required both for protein trafficking to the
vacuole (Raymond et al., 1992; Harding et al., 1995;
Cowles et al., 1997; Nakamura et al., 1997) as well as for
homotypic vacuole–vacuole fusion. Surprisingly, recent
findings have suggested a novel function for Vam2/
Vps41p. Emr and colleagues (Rehling et al., 1999) have
shown that this protein is required for the formation of ve-
sicular transport intermediates of the vacuole ALP (al-
kaline phosphatase) pathway at the trans-Golgi. They
further demonstrated that Vam2/Vps41p interacts with
components of a clathrin coat adapter complex by binding
directly to the AP-3 subunit Apl5. On the other hand, we
find that Vam2 and its partner protein Vam6 (Nakamura
et al., 1997; Price et al., accompanying manuscript) are re-
quired for the docking stage of homotypic vacuole fu-
sion. The fragmented vacuole phenotype seen in vam2
and vam6 mutants is identical to that seen in mutants of
the small G protein Vam4/Ypt7p and the vacuolar
t-SNARE (Wada et al., 1992; Haas et al., 1995; Naka-
mura et al., 1997; Nichols et al., 1997). Each of these pro-
teins has been shown biochemically to act at the docking
stage of the homotypic vacuole fusion reaction. Vam2p
and Vam6p localize to the vacuole in vivo (Nakamura et
al., 1997); additional localization to the Golgi or Golgi-
derived vesicles might have been difficult to visualize.
Vam2p and Vam6p presumably use different receptors at
the Golgi and vacuole, which is consistent with the find-
ings that vacuolar Ypt7p is needed for optimal steady state
association of Vam2p and Vam6p at the vacuole (Price et
al., 2000 [this issue]) and, yet, normal budding of traffick-
ing vesicles from the Golgi (Rehling et al., 1999) may not
require Ypt7p. We have shown that approximately half of
the Vam2 and Vam6 copurify with vacuoles (when com-
pared with the vacuole marker protein Pho8p), whereas
Kex2p, a trans-Golgi marker protein, does not (Fig. 1).
In the accompanying manuscript (Price et al., 2000 [this is-
sue]), we demonstrate that both Vam2p and Vam6p are phys-
ically and functionally associated with factors specifically re-
quired for homotypic vacuole fusion. Except for the study
Figure 7. Vam2/6p continues to function after Ypt7p. Standard
fusion reactions were supplemented with cytosol and excess
Sec18p (3.8 mg) to prevent SNARE pairing and incubated on ice
(lane 1) or at 278C for 20 min. After 20 min, one reaction was
placed on ice (lane 2), the others received inhibitors or antibodies
and were placed on ice for 3 min. Reactions were diluted with 500
ml PS buffer. Vacuoles were sedimented (for 5 min, 10,000 g, at
48C) and resuspended in the original volume of reaction buffer
(without cytosol and Sec18p). The indicated inhibitors were
added and the reaction continued for 70 min at 278C. Fusion ac-
tivity was measured and background activity (0.25 U) was sub-
tracted.
Figure 8. Vam2/6p is required for trans-SNARE pairing. The
formation of trans-SNARE pairs between vacuoles was assayed
as described in Ungermann et al. (1998). Vacuoles from strains
BJ3505nyv1D and DKY6281vam3D (100 mg each) were incu-
bated together at 278C (lanes 2–4) or on ice (lane 1) with cytosol
and ATP for 30 min. Reactions were supplemented with control
buffer (lanes 1 and 2), affinity-purified anti-Vam2p IgG (lane 3),
or affinity-purified anti-Vam2p Fab fragment (lane 4). Protein
complexes were analyzed by coimmunoprecipitation with protein
A–immobilized antibodies to Vam3p, SDS-PAGE, and immuno-
blotting with antibodies to Vam3p and Nyv1p.
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of Springer and Schekman (1998), which showed that
SNARE proteins nucleate COPII budding from the yeast
ER, there is little precedent for such an unusual dual func-
tion in both vesicle budding and membrane docking. This
raises the fascinating possibility that Vam2/6p may couple
these processes in vivo. Further work will be required to
test this idea.
Since many of the same proteins are needed for hetero-
typic trafficking to the vacuole and for homotypic vacu-
ole fusion, the recovery of organelles with vacuole den-
sity from lysates of vam2D, vam6D, vam3D, and ypt7D
strains, and the demonstration that these organelles con-
tain vacuole marker proteins at approximately normal
specific activities, raises a question of their identity and or-
igins. They may be small, but rather normal, vacuoles that
have obtained most of their proteins by slow, or even by-
pass, pathways and are small because of defective homo-
typic fusion. Alternatively, they may represent an earlier
organelle on the Golgi to vacuole pathways that has ex-
panded because of accumulated vacuole proteins until it
acquires certain vacuole characteristics such as density.
Further studies are needed to resolve this yet, in either
case, assay of the capacity of this organelle to fuse with
vacuoles from wild-type cells provides one measure of the
role of the missing protein in fusion pathways. Other com-
plementary assays are inhibition of the homotypic fusion
of wild-type vacuoles by the relevant antibody and, as de-
tailed for Vam2p and Vam6p in the accompanying manu-
script (Price et al., 2000), direct demonstration of physical
and functional associations with other catalysts of vacuole
fusion such as Ypt7p and SNAREs.
How general is the yeast vacuole and the role of Vam2p
and Vam6p in its fusion as a model for priming and dock-
ing in other vesicle trafficking pathways? Yeast vacuoles
require priming before docking (Mayer and Wickner,
1997) and, in this regard, might be thought to differ, at
least superficially, from other trafficking reactions. For ex-
ample, the priming of SNAREs by NSF and SNAP is not
needed for docking at the neural synapse in Drosophila
(Littleton et al., 1998) and Cao et al. (1998) have shown
that the docking of ER-derived vesicles at the Golgi re-
quires Uso1p but not the priming of SNAREs by Sec18p.
However, we suggest that there is a fundamental unity in
these three systems. Vacuole tethering is mediated by
Ypt7p, but it is not mediated by the pairing of SNAREs in
trans (Ungermann et al., 1998). Vacuoles from a vam3D
strain, in which the SNAREs are not associated in cis with
each other (Ungermann and Wickner, 1998), can also
tether without priming (Ungermann et al., 1998), as in
the studies of Cao et al. (1998). Furthermore, since synap-
tic transmission is sensitive to some proteolytic toxins that
only cleave unpaired SNAREs (Otto et al., 1997) and at-
tachment of vesicles to the presynaptic membrane is unaf-
fected by SNARE mutants (Broadie et al., 1995), the mor-
phologically docked state at the synapse may correspond
to tethering but not to complete trans-SNARE pairing.
We propose that the disassembly of v- and t-SNAREs
after heterotypic fusion and the sorting of the v- and
t-SNAREs at the start of v-SNARE retrograde traffic may
spatially disconnect the priming activity of Sec18p/NSF
from docking, whereas these events are necessarily linked
in homotypic fusion reactions.
The docking process is now known to require an unex-
pected variety of factors. These include t- and v-SNAREs
on apposed vacuoles (Nichols et al., 1997), the Rab-like
Ypt7p on both vacuoles (Haas et al., 1995), vacuolar phos-
phatidylinositol 4,5-bisphosphate (Mayer et al., 2000), vac-
uole acidification (Ungermann et al., 1999b), and now
Vam2p and Vam6p. The relationships between these fac-
tors are not clear. However, in an accompanying paper, we
show that a complex that contains Vam2p and Vam6p
functions as an effector complex for Ypt7p, linking mem-
brane priming to trans-SNARE pairing. Our finding (Fig.
7) that Vam2p is still needed even after Ypt7p has com-
pleted its function suggests that Vam2p might function be-
tween Ypt7p-mediated tethering and trans-SNARE pair-
ing. This result is consistent with the finding that Vam2p is
needed for trans-SNARE pairing (Fig. 8), but further
studies will be needed to test this hypothesis.
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